Vivaldi Capital Management LP Indaptus Therapeutics, Inc. Transaction History

Vivaldi Capital Management LP

  • $689 Million
  • Q3 2025

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
BUY
$3.19 - $6.17 $76,560 - $148,080
24,000 New
24,000 $60,000

Others Institutions Holding INDP

# of Institutions
1
Shares Held
43.9K
Call Options Held
0
Put Options Held
0
View Full List

About Indaptus Therapeutics, Inc.

INDP Quotes by TradingView
  • Ticker INDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,258,600
  • Market Cap $20.7M
  • Description
  • Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as hepatitis B v...
More about INDP
Track This Portfolio

Track Vivaldi Capital Management LP Portfolio

Follow Vivaldi Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vivaldi Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Vivaldi Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email